Coagulation Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications, Type, Offering, Technology, End User, and Geography

List of Tables

The coagulation market is expected to grow from US$ 6.295 billion in 2022 to US$ 10.853 billion by 2030; it is anticipated to record a CAGR of 7.0% from 2022 to 2030.

Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.

In July 2020, Sysmex Corporation launched the Automated Blood Coagulation Analyzers CN-6500/CN-3500 in Japan. The analyzer measures blood coagulation and platelet aggregation parameters, as well as thrombosis and hemostasis parameters.

In April 2020, US-based Haemonetics Corporation acquired Enicor, a blood coagulation diagnostic system developer.

In October 2021, Trivitron Healthcare launched a new line of coagulation analyzer products manufactured by Diagon Ltd in India.

In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.

In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex's automated blood coagulation analyzer, such as the CN-3000 and CN-6000.

In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation tests. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.

Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period.

Rising Prevalence of Cardiovascular Diseases drives the growth the Coagulation Market

Heart disease is one of the leading causes of hospitalization, death, and reduced physical performance due to conditions such as atrial fibrillation and stroke. It affects the hemostatic system, vascular system, and fluid dynamics of blood and causes arterial and venous thrombosis. Thrombosis is the leading cause of death and complications from cardiovascular disease. Blood vessels damaged by smoking and high blood pressure form cholesterol-rich plaques lining the blood vessels, which can rupture and cause platelets to clot. With coagulation disorders, there is a risk of myocardial infarction, stroke, and atherothrombotic events in the vascular beds. Heart failure (HF) is related to an increased risk of thromboembolism independent of the presence of atrial fibrillation (AF). Platelet activation and coagulation system abnormalities can increase the risk of serious thromboembolic events in patients suffering from HF.

According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, ~119.1 million deaths due to CVDs and around 89.1 million and 68.2 million stroke and ischemic stroke cases, respectively, are recorded across the world in 2020. Per the National Center for Chronic Disease Prevention and Health Promotion, in 2023, the US reports ~877,500 deaths due to heart diseases every year. According to the American Heart Association, more than 130 million Americans are likely to acquire some form of CVD by 2035. As per 'Global Burden of Disease Study 2019,' CVDs were the leading cause of deaths in Asia Pacific in 2019, causing 10.8 million or 35% of the total fatalities.

A coagulation test helps prevent potential heart attack-causing blood clotting. A coagulation analyzer is used during coronary artery bypass surgery and angioplasty to monitor information on blood clotting status. Thus, the growing incidence of cardiovascular diseases bolsters the coagulation market growth.

The coagulation market is segmented on the basis of disease indication, type, offering, technology, end user, and geography. Based on disease indication, the coagulation market is segmented into vitamin K deficiency, liver disease, disseminated intravascular coagulation & pulmonary embolism, circulating anticoagulant development, hemophilia, von Willebrand's disease, and others. Based on type, the coagulation market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. Clinical laboratory analyzers consist of controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others. Based on offering, the coagulation market is segmented into diagnosis and treatment. The diagnosis segment is further classified into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, D-dimmer testing, platelets function testing, and others. The treatment segment is further classified into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin K supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapies, catheter-assisted thrombus removal, and others. Based on technology, the coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. Based on end user, the coagulation market is segmented into clinical laboratories, hospitals, and others.

Based on geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the coagulation market. North America accounts for a significant market share owing to the growing incidences of blood disorders, increasing occurrence of cardiovascular diseases such as atrial fibrillation (AFib), and the presence of major market players engaged in new and existing product developments. The US holds the largest share of the coagulation market in North America. The burgeoning cases of blood disorders, growing prevalence of cardiovascular diseases, and government support for preventing blood disorders are anticipated to boost the North America coagulation market growth during the forecast period. As per the Canadian Task Force on Preventive Health Care, the incidence of AFib in Canada increases by 4.5% per year, with a lifetime risk of ~25% among people aged more than 40 years. Approximately 300,000 Canadians carry an inherited bleeding disorder gene. 1 in 10 of these people-at least 30,000 Canadians-have symptoms severe enough to require medical care. Many of them have not been properly diagnosed. Only 10,000 people with inherited bleeding disorders are registered in the Canadian network of comprehensive care clinics for inherited bleeding disorders. According to the Canadian Hemophilia Society, ~300,000 Canadians carry a gene for an inherited blood disorder. Thus, the rising number of cases of congenital blood disorders can be associated with the growth of the coagulation market in Canada.

American Heart Association (AHA), Centers for Disease Control and Prevention (CDC), European Union, and Canadian Task Force on Preventive Health Care are a few key primary and secondary sources referred to while preparing the report on the coagulation market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the coagulation market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the coagulation market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the coagulation market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Product Code: TIPRE00030085

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Coagulation Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Coagulation Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Market Drivers
- 5.1.2 Increasing Prevalence of Blood Disorders
- 5.1.3 Rising Prevalence of Cardiovascular Diseases
5.2 Market Restraints
- 5.2.1 High Costs Associated with Coagulation Analyzers
5.3 Market Opportunities
- 5.3.1 Growing Organic and Inorganic Strategies by Key Market Players
5.4 Future Trends
- 5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.5 Impact Analysis

6. Coagulation Market - Global Market Analysis

6.1 Coagulation Market Revenue (US$ million), 2022 - 2030
6.2 Geography Analysis Market Revenue (US$ million), 2022 - 2030

7. Global Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

7.1 Overview
7.2 Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
7.3 Vitamin K Deficiency
- 7.3.1 Overview
- 7.3.2 Vitamin K Deficiency: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Liver Disease
- 7.4.1 Overview
- 7.4.2 Liver Disease: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
- 7.5.1 Overview
- 7.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Development of Circulating Anticoagulant
- 7.6.1 Overview
- 7.6.2 Development of Circulating Anticoagulant: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Hemophilia
- 7.7.1 Overview
- 7.7.2 Hemophilia: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Von Willebrand's Disease
- 7.8.1 Overview
- 7.8.2 Von Willebrand's Disease: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Coagulation Market - Revenue and Forecast to 2030 - by Type

8.1 Overview
8.2 Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
8.3 Clinical Laboratory Analyzers
- 8.3.1 Overview
- 8.3.2 Clinical Laboratory Analyzers: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Global Coagulation Market, by Clinical Laboratory Analyzers
8.4 Point-of-Care Testing Analyzers
- 8.4.1 Overview
- 8.4.2 Point-of-Care Testing Analyzers: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Coagulation Market - Revenue and Forecast to 2030 - by Offering

9.1 Overview
9.2 Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
9.3 Diagnosis
- 9.3.1 Overview
- 9.3.2 Diagnosis: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.3.2.1 Global Coagulation Market, by Diagnosis
9.4 Treatment
- 9.4.1 Overview
- 9.4.2 Treatment: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.4.2.1 Global Coagulation Market, by Treatment

10. Global Coagulation Market - Revenue and Forecast to 2030 - by Technology

10.1 Overview
10.2 Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
10.3 Optical Technology
- 10.3.1 Overview
- 10.3.2 Optical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Mechanical Technology
- 10.4.1 Overview
- 10.4.2 Mechanical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Electrochemical Technology
- 10.5.1 Overview
- 10.5.2 Electrochemical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Global Coagulation Market - Revenue and Forecast to 2030 - by End User

11.1 Overview
11.2 Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
11.3 Clinical Laboratories
- 11.3.1 Overview
- 11.3.2 Clinical Laboratories: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals
- 11.4.1 Overview
- 11.4.2 Hospitals: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

12. Coagulation Market - Geographical Analysis

12.1 North America Coagulation Market, Revenue And Forecast To 2030
- 12.1.1 Overview
- 12.1.2 North America Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.1.3 North America Coagulation Market, by Disease Indication
- 12.1.4 North America Coagulation Market, by Type
  - 12.1.4.1 North America Coagulation Market, by Clinical Laboratory Analyzers
- 12.1.5 North America Coagulation Market, by Offering
  - 12.1.5.1 North America Coagulation Market, by Diagnosis
  - 12.1.5.2 North America Coagulation Market, by Treatment
- 12.1.6 North America Coagulation Market, by Technology
- 12.1.7 North America Coagulation Market, by End User
  - 12.1.7.1 North America Coagulation Market, by Country
  - 12.1.7.2 US
    - 12.1.7.2.1 Overview
    - 12.1.7.2.2 US Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.1.7.2.3 US Coagulation Market, by Disease Indication
    - 12.1.7.2.4 US Coagulation Market, by Type
    - 12.1.7.2.4.1 US Coagulation Market, by Clinical Laboratory Analyzers
    - 12.1.7.2.5 US Coagulation Market, by Offering
    - 12.1.7.2.5.1 US Coagulation Market, by Diagnosis
    - 12.1.7.2.5.2 US Coagulation Market, by Treatment
    - 12.1.7.2.6 US Coagulation Market, by Technology
    - 12.1.7.2.7 US Coagulation Market, by End User
  - 12.1.7.3 Canada
    - 12.1.7.3.1 Overview
    - 12.1.7.3.2 Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.1.7.3.3 Canada Coagulation Market, by Disease Indication
    - 12.1.7.3.4 Canada Coagulation Market, by Type
    - 12.1.7.3.4.1 Canada Coagulation Market, by Clinical Laboratory Analyzers
    - 12.1.7.3.5 Canada Coagulation Market, by Offering
    - 12.1.7.3.5.1 Canada Coagulation Market, by Diagnosis
    - 12.1.7.3.5.2 Canada Coagulation Market, by Treatment
    - 12.1.7.3.6 Canada Coagulation Market, by Technology
    - 12.1.7.3.7 Canada Coagulation Market, by End User
  - 12.1.7.4 Mexico
    - 12.1.7.4.1 Overview
    - 12.1.7.4.2 Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.1.7.4.3 Mexico Coagulation Market, by Disease Indication
    - 12.1.7.4.4 Mexico Coagulation Market, by Type
    - 12.1.7.4.4.1 Mexico Coagulation Market, by Clinical Laboratory Analyzers
    - 12.1.7.4.5 Mexico Coagulation Market, by Offering
    - 12.1.7.4.5.1 Mexico Coagulation Market, by Diagnosis
    - 12.1.7.4.5.2 US Coagulation Market, by Treatment
    - 12.1.7.4.6 Mexico Coagulation Market, by Technology
    - 12.1.7.4.7 Mexico Coagulation Market, by End User
12.2 Europe Coagulation Market, Revenue And Forecast to 2030
- 12.2.1 Overview
- 12.2.2 Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.2.3 Europe Coagulation Market, by Disease Indication
- 12.2.4 Europe Coagulation Market, by Type
  - 12.2.4.1 Europe Coagulation Market, by Clinical Laboratory Analyzers
- 12.2.5 Europe Coagulation Market, by Offering
  - 12.2.5.1 Europe Coagulation Market, by Diagnosis
  - 12.2.5.2 Europe Coagulation Market, by Treatment
- 12.2.6 Europe Coagulation Market, by Technology
- 12.2.7 Europe Coagulation Market, by End User
- 12.2.8 Europe Coagulation Market by Country
  - 12.2.8.1 Germany
    - 12.2.8.1.1 Overview
    - 12.2.8.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.1.3 Germany Coagulation Market, by Disease Indication
    - 12.2.8.1.4 Germany Coagulation Market, by Type
    - 12.2.8.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.1.5 Germany Coagulation Market, by Offering
    - 12.2.8.1.5.1 Germany Coagulation Market, by Diagnosis
    - 12.2.8.1.5.2 Germany Coagulation Market, by Treatment
    - 12.2.8.1.6 Germany Coagulation Market, by Technology
    - 12.2.8.1.7 Germany Coagulation Market, by End User
  - 12.2.8.2 UK
    - 12.2.8.2.1 Overview
    - 12.2.8.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.2.2 UK Coagulation Market, by Disease Indication
    - 12.2.8.2.3 UK Coagulation Market, by Type
    - 12.2.8.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.2.4 UK Coagulation Market, by Offering
    - 12.2.8.2.4.1 UK Coagulation Market, by Diagnosis
    - 12.2.8.2.4.2 UK Coagulation Market, by Treatment
    - 12.2.8.2.5 UK Coagulation Market, by Technology
    - 12.2.8.2.6 UK Coagulation Market, by End User
  - 12.2.8.3 France
    - 12.2.8.3.1 Overview
    - 12.2.8.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.3.2 France Coagulation Market, by Disease Indication
    - 12.2.8.3.3 France Coagulation Market, by Type
    - 12.2.8.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.3.4 France Coagulation Market, by Offering
    - 12.2.8.3.4.1 France Coagulation Market, by Diagnosis
    - 12.2.8.3.4.2 France Coagulation Market, by Treatment
    - 12.2.8.3.5 France Coagulation Market, by Technology
    - 12.2.8.3.6 France Coagulation Market, by End User
  - 12.2.8.4 Italy
    - 12.2.8.4.1 Overview
    - 12.2.8.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.4.2 Italy Coagulation Market, by Disease Indication
    - 12.2.8.4.3 Italy Coagulation Market, by Type
    - 12.2.8.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.4.4 Italy Coagulation Market, by Offering
    - 12.2.8.4.4.1 Italy Coagulation Market, by Diagnosis
    - 12.2.8.4.4.2 Italy Coagulation Market, by Treatment
    - 12.2.8.4.5 Italy Coagulation Market, by Technology
    - 12.2.8.4.6 Italy Coagulation Market, by End User
  - 12.2.8.5 Spain
    - 12.2.8.5.1 Overview
    - 12.2.8.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.5.3 Spain Coagulation Market, by Disease Indication
    - 12.2.8.5.4 Spain Coagulation Market, by Type
    - 12.2.8.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.5.5 Spain Coagulation Market, by Offering
    - 12.2.8.5.5.1 Spain Coagulation Market, by Diagnosis
    - 12.2.8.5.5.2 Spain Coagulation Market, by Treatment
    - 12.2.8.5.6 Spain Coagulation Market, by Technology
    - 12.2.8.5.7 Spain Coagulation Market, by End User
  - 12.2.8.6 Rest of Europe
    - 12.2.8.6.1 Overview
    - 12.2.8.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.6.3 Rest of Europe Coagulation Market, by Disease Indication
    - 12.2.8.6.4 Rest of Europe Coagulation Market, by Type
    - 12.2.8.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.6.5 Rest of Europe Coagulation Market, by Offering
    - 12.2.8.6.5.1 Rest of Europe Coagulation Market, by Diagnosis
    - 12.2.8.6.5.2 Rest of Europe Coagulation Market, by Treatment
    - 12.2.8.6.6 Rest of Europe Coagulation Market, by Technology
    - 12.2.8.6.7 Rest of Europe Coagulation Market, by End User
12.3 Asia Pacific Coagulation Market, Revenue and Forecast to 2030
- 12.3.1 Overview
- 12.3.2 Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.3.3 Asia Pacific Coagulation Market, by Disease Indication
- 12.3.4 Asia Pacific Coagulation Market, by Type
  - 12.3.4.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
- 12.3.5 Asia Pacific Coagulation Market, by Offering
  - 12.3.5.1 Asia Pacific Coagulation Market, by Diagnosis
  - 12.3.5.2 Asia Pacific Coagulation Market, by Treatment
- 12.3.6 Asia Pacific Coagulation Market, by Technology
- 12.3.7 Asia Pacific Coagulation Market, by End User
- 12.3.8 Asia Pacific Coagulation Market by Country
  - 12.3.8.1 China
    - 12.3.8.1.1 Overview
    - 12.3.8.1.2 China Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.1.3 China Coagulation Market, by Disease Indication
    - 12.3.8.1.4 China Coagulation Market, by Type
    - 12.3.8.1.4.1 China Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.1.5 China Coagulation Market, by Offering
    - 12.3.8.1.5.1 China Coagulation Market, by Diagnosis
    - 12.3.8.1.5.2 China Coagulation Market, by Treatment
    - 12.3.8.1.6 China Coagulation Market, by Technology
    - 12.3.8.1.7 China Coagulation Market, by End User
  - 12.3.8.2 Japan
    - 12.3.8.2.1 Overview
    - 12.3.8.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.2.3 Japan Coagulation Market, by Disease Indication
    - 12.3.8.2.4 Japan Coagulation Market, by Type
    - 12.3.8.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.2.5 Japan Coagulation Market, by Offering
    - 12.3.8.2.5.1 Japan Coagulation Market, by Diagnosis
    - 12.3.8.2.5.2 Japan Coagulation Market, by Treatment
    - 12.3.8.2.6 Japan Coagulation Market, by Technology
    - 12.3.8.2.7 Japan Coagulation Market, by End User
  - 12.3.8.3 India
    - 12.3.8.3.1 Overview
    - 12.3.8.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.3.3 India Coagulation Market, by Disease Indication
    - 12.3.8.3.4 India Coagulation Market, by Type
    - 12.3.8.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.3.5 India Coagulation Market, by Offering
    - 12.3.8.3.5.1 India Coagulation Market, by Diagnosis
    - 12.3.8.3.5.2 India Coagulation Market, by Treatment
    - 12.3.8.3.6 India Coagulation Market, by Technology
    - 12.3.8.3.7 India Coagulation Market, by End User
  - 12.3.8.4 Australia
    - 12.3.8.4.1 Overview
    - 12.3.8.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.4.3 Australia Coagulation Market, by Disease Indication
    - 12.3.8.4.4 Australia Coagulation Market, by Type
    - 12.3.8.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.4.5 Australia Coagulation Market, by Offering
    - 12.3.8.4.5.1 Australia Coagulation Market, by Diagnosis
    - 12.3.8.4.5.2 Australia Coagulation Market, by Treatment
    - 12.3.8.4.6 Australia Coagulation Market, by Technology
    - 12.3.8.4.7 Australia Coagulation Market, by End User
  - 12.3.8.5 South Korea
    - 12.3.8.5.1 Overview
    - 12.3.8.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.5.3 South Korea Coagulation Market, by Disease Indication
    - 12.3.8.5.4 South Korea Coagulation Market, by Type
    - 12.3.8.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.5.5 South Korea Coagulation Market, by Offering
    - 12.3.8.5.5.1 South Korea Coagulation Market, by Diagnosis
    - 12.3.8.5.5.2 South Korea Coagulation Market, by Treatment
    - 12.3.8.5.6 South Korea Coagulation Market, by Technology
    - 12.3.8.5.7 South Korea Coagulation Market, by End User
  - 12.3.8.6 Rest of Asia Pacific
    - 12.3.8.6.1 Overview
    - 12.3.8.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication
    - 12.3.8.6.4 Rest of Asia Pacific Coagulation Market, by Type
    - 12.3.8.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.6.5 Rest of Asia Pacific Coagulation Market, by Offering
    - 12.3.8.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis
    - 12.3.8.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment
    - 12.3.8.6.6 Rest of Asia Pacific Coagulation Market, by Technology
    - 12.3.8.6.7 Rest of Asia Pacific Coagulation Market, by End User
12.4 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030
- 12.4.1 Overview
- 12.4.2 Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.4.3 Middle East & Africa Coagulation Market, by Disease Indication
- 12.4.4 Middle East & Africa Coagulation Market, by Type
  - 12.4.4.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
- 12.4.5 Middle East & Africa Coagulation Market, by Offering
  - 12.4.5.1 Middle East & Africa Coagulation Market, by Diagnosis
  - 12.4.5.2 Middle East & Africa Coagulation Market, by Treatment
- 12.4.6 Middle East & Africa Coagulation Market, by Technology
- 12.4.7 Middle East & Africa Coagulation Market, by End User
  - 12.4.7.1 Middle East & Africa Coagulation Market by Country
  - 12.4.7.2 Saudi Arabia
    - 12.4.7.2.1 Overview
    - 12.4.7.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.2.3 Saudi Arabia Coagulation Market, by Disease Indication
    - 12.4.7.2.4 Saudi Arabia Coagulation Market, by Type
    - 12.4.7.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.2.5 Saudi Arabia Coagulation Market, by Offering
    - 12.4.7.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis
    - 12.4.7.2.5.2 Saudi Arabia Coagulation Market, by Treatment
    - 12.4.7.2.6 Saudi Arabia Coagulation Market, by Technology
    - 12.4.7.2.7 Saudi Arabia Coagulation Market, by End User
  - 12.4.7.3 South Africa
    - 12.4.7.3.1 Overview
    - 12.4.7.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.3.3 South Africa Coagulation Market, by Disease Indication
    - 12.4.7.3.4 South Africa Coagulation Market, by Type
    - 12.4.7.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.3.5 South Africa Coagulation Market, by Offering
    - 12.4.7.3.5.1 South Africa Coagulation Market, by Diagnosis
    - 12.4.7.3.5.2 South Africa Coagulation Market, by Treatment
    - 12.4.7.3.6 South Africa Coagulation Market, by Technology
    - 12.4.7.3.7 South Africa Coagulation Market, by End User
  - 12.4.7.4 UAE
    - 12.4.7.4.1 Overview
    - 12.4.7.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.4.3 UAE Coagulation Market, by Disease Indication
    - 12.4.7.4.4 UAE Coagulation Market, by Type
    - 12.4.7.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.4.5 UAE Coagulation Market, by Offering
    - 12.4.7.4.5.1 UAE Coagulation Market, by Diagnosis
    - 12.4.7.4.5.2 UAE Coagulation Market, by Treatment
    - 12.4.7.4.6 UAE Coagulation Market, by Technology
    - 12.4.7.4.7 UAE Coagulation Market, by End User
  - 12.4.7.5 Rest of Middle East & Africa
    - 12.4.7.5.1 Overview
    - 12.4.7.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication
    - 12.4.7.5.4 Rest of Middle East & Africa Coagulation Market, by Type
    - 12.4.7.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.5.5 Rest of Middle East & Africa Coagulation Market, by Offering
    - 12.4.7.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis
    - 12.4.7.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment
    - 12.4.7.5.6 Rest of Middle East & Africa Coagulation Market, by Technology
    - 12.4.7.5.7 Rest of Middle East & Africa Coagulation Market, by End User
12.5 South & Central America Coagulation Market, Revenue and Forecast to 2030
- 12.5.1 Overview
- 12.5.2 South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.5.3 South & Central America Coagulation Market, by Disease Indication
- 12.5.4 South & Central America Coagulation Market, by Type
  - 12.5.4.1 South & Central America Coagulation Market, by Clinical Laboratory Analyzer
- 12.5.5 South & Central America Coagulation Market, by Offering
  - 12.5.5.1 South & Central America Coagulation Market, by Diagnosis
  - 12.5.5.2 South & Central America Coagulation Market, by Treatment
- 12.5.6 South & Central America Coagulation Market, by Technology
- 12.5.7 South & Central America Coagulation Market, by End User
- 12.5.8 South & Central America Coagulation Market by Country
  - 12.5.8.1 Brazil
    - 12.5.8.1.1 Overview
    - 12.5.8.1.2 Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.5.8.1.3 Brazil Coagulation Market, by Disease Indication
    - 12.5.8.1.4 Brazil Coagulation Market, by Type
    - 12.5.8.1.4.1 Brazil Coagulation Market, by Clinical Laboratory Analyzer
    - 12.5.8.1.5 Brazil Coagulation Market, by Offering
    - 12.5.8.1.5.1 Brazil Coagulation Market, by Diagnosis
    - 12.5.8.1.5.2 Brazil Coagulation Market, by Treatment
    - 12.5.8.1.6 Brazil Coagulation Market, by Technology
    - 12.5.8.1.7 Brazil Coagulation Market, by End User
  - 12.5.8.2 Argentina
    - 12.5.8.2.1 Overview
    - 12.5.8.2.2 Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.5.8.2.3 Argentina Coagulation Market, by Disease Indication
    - 12.5.8.2.4 Argentina Coagulation Market, by Type
    - 12.5.8.2.4.1 Argentina Coagulation Market, by Clinical Laboratory Analyzer
    - 12.5.8.2.5 Argentina Coagulation Market, by Offering
    - 12.5.8.2.5.1 Argentina Coagulation Market, by Diagnosis
    - 12.5.8.2.5.2 Argentina Coagulation Market, by Treatment
    - 12.5.8.2.6 Argentina Coagulation Market, by Technology
    - 12.5.8.2.7 Argentina Coagulation Market, by End User
  - 12.5.8.3 Rest of South & Central America
    - 12.5.8.3.1 Overview
    - 12.5.8.3.2 Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.5.8.3.3 Rest of South & Central America Coagulation Market, by Disease Indication
    - 12.5.8.3.4 Rest of South & Central America Coagulation Market, by Type
    - 12.5.8.3.4.1 Rest of South & Central America Coagulation Market, by Clinical Laboratory Analyzer
    - 12.5.8.3.5 Rest of South & Central America Coagulation Market, by Offering
    - 12.5.8.3.5.1 Rest of South & Central America Coagulation Market, by Diagnosis
    - 12.5.8.3.5.2 Rest of South & Central America Coagulation Market, by Treatment
    - 12.5.8.3.6 Rest of South & Central America Coagulation Market, by Technology
    - 12.5.8.3.7 Rest of South & Central America Coagulation Market, by End User

13. Coagulation Market-Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Coagulation Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Siemens Healthineers AG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Diagnostica Stago, Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 ImproGen Diagnostik Kimya San. & Tic. Ltd.?ti.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Nordic Biomarker AB
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Sysmex Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Helena Laboratories Corporation
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 F. Hoffmann-La Roche Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Genrui Biotech Co., Ltd.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Transasia Bio-Medicals Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Horiba Ltd.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About Us
15.2 Glossary of Terms